Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02178839
What this trial is testing

The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Urmia University of Medical Sciences 48
Not applicableStudy completedNCT03566173
What this trial is testing

Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis

Who this might be right for
Acute PancreatitisNonalcoholic Fatty Liver Disease
Ningbo No. 1 Hospital 1,662
Early research (Phase 1)UnknownNCT04481594
What this trial is testing

Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Hepanova Inc. 72
Not applicableStudy completedNCT06697977
What this trial is testing

Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDInsulin ResistanceMetabolic Syndrome+4 more
University of Jordan 27
Not applicableStudy completedNCT04779905
What this trial is testing

Chronic Kidney Disease and Non-alcoholic Fatty Liver Diseases

Who this might be right for
Chronic Kidney DiseasesNAFLD
Sohag University 62
Not applicableStudy completedNCT05194553
What this trial is testing

Identification and Characterization of NAFLD in Turkey

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver DiseasesFatty Liver+2 more
Maastricht University 450
Not applicableStudy completedNCT03583437
What this trial is testing

Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD.

Who this might be right for
NAFLD - Nonalcoholic Fatty Liver Disease
University of Aarhus 17
Not applicableStudy completedNCT04523584
What this trial is testing

Ultrasound Quantification of Liver Fat

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Children's Hospital Medical Center, Cincinnati 192
Not applicableUnknownNCT04781933
What this trial is testing

Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Mativa-Tech SA 60
Not applicableStudy completedNCT03836443
What this trial is testing

Postprandial Lipotoxicity and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Assistance Publique - Hôpitaux de Paris 30
Not applicableStudy completedNCT01327443
What this trial is testing

Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Missouri-Columbia 17
Not applicableLooking for participantsNCT06856252
What this trial is testing

Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH)

Who this might be right for
NAFLD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 60
Large-scale testing (Phase 3)Ended earlyNCT04237116
What this trial is testing

Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Plaque PsoriasisNon-alcoholic Fatty Liver Disease
Novartis Pharmaceuticals 10
Early research (Phase 1)Active Not RecruitingNCT06947304
What this trial is testing

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics 9
Not applicableEnded earlyNCT05579444
What this trial is testing

Systems Biology of Gastrointestinal and Related Diseases

Who this might be right for
Ulcerative ColitisCrohn DiseaseObesity+19 more
Viome 17
Not applicableStudy completedNCT04548232
What this trial is testing

Clinical Efficacy and Safety of a Laparoscopic Sleeve Gastrectomy in Obese Patients

Who this might be right for
Obesity
Shanghai 10th People's Hospital 300
Not applicableNot Yet RecruitingNCT07128147
What this trial is testing

Detection of Helicopacter Pylori in Patients With Metabolic Associated Fatty Liver Disease

Who this might be right for
Helicobacter Pylori Infection Metabolic Dysfunction-Associated Fatty Liver Disease
Assiut University 200
Post-approval studies (Phase 4)Study completedNCT02303730
What this trial is testing

Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease
Fudan University 76
Not applicableStudy completedNCT02875392
What this trial is testing

Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-alcoholic Fatty Liver Disease
Taipei Medical University WanFang Hospital 57
Post-approval studies (Phase 4)Ended earlyNCT02500147
What this trial is testing

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary SyndromeNon-Alcoholic Fatty Liver DiseaseMetabolic Syndrome
Columbia University 3
Next Page